Yoo Jin Na

Dr. Yoo Jin Na

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
YNYoo Jin Na
Yoo Jin Na
OJOeuk Jeong
Oeuk Jeong
JSJaehyun Seong
Jaehyun Seong
JLJeongGyu Lee
JeongGyu Lee
SLSo Young Lee
So Young Lee
SRSangmi Ryou
Sangmi Ryou
Na YJ, et al. J Gynecol Oncol. 2024 Jan;35(5):e56. https://doi.org/10.3802/jgo.2024.35.e56

3 April 2023
Verified
Other
Open access
BKBo Ram Kim
Bo Ram Kim
YJYoon A. Jeong
Yoon A. Jeong
MJMin Jee Jo
Min Jee Jo
SPSeong Hye Park
Seong Hye Park
YNYoo Jin Na
Yoo Jin Na
SOSang Cheul Oh
Sang Cheul Oh
Supplementary Fig. 1. Genipin enhanced oxaliplatin sensitivity, but not geniposide in HCT116. Supplementary Fig. 2. Genipin increased oxaliplatin-induced apoptosis in DLD-1. Supplementary Fig. 3. Genipin induced the activation of the ROS-ER stress-JNK pathway. Supplemental Fig. 4 Combination of oxaliplatin and genipin decreased tumor growth in vivo.

25 January 2026 in Vaccines
Verified
Journal Article
Open access
PDF file
SHSeokhwan Hyeon
Seokhwan Hyeon
KKKwangwook Kim
Kwangwook Kim
YNYoo Jin Na
Yoo Jin Na
MKMihee Kim
Mihee Kim
JJJaenam Jeong
Jaenam Jeong
YLYoo-kyoung Lee
Yoo-kyoung Lee
Background: Dengue virus (DENV) is becoming a global public health problem, but the immunogenicity of DENV structural proteins is not fully understood. Methods: We predicted the epitope-based immunogenicity of DENV proteins from four serotypes in silico and evaluated their efficacy in vitro (T-cell proliferation assays) and in vivo (ELISpot, qRT-PCR, and plaque reduction neutralization tests using murine splenocytes). We focused on the envelope protein, which contains envelope domain III. Immunogenic B-cell epitopes were predicted using BepiPred-2.0, and regions that induce T cell-mediated immune responses were analyzed using the immune epitope database (IEDB), which validates peptides presented on HLA class I. Results: Nine-amino-acid peptide candidates were selected based on a score of >0.1. The best peptide candidates were tested in T-cell proliferation assays to confirm the in silico data. Subsequently, BALB/c mice were vaccinated with candidate peptides showing immunity in the proliferation assay, and their splenocytes were analyzed. ELISpot and qRT-PCR data showed that some candidate peptides highly regulated cytokines, including interferon-γ, tumor necrosis factor-α, and interleukin-4. Murine sera were collected after peptide boosting 2 weeks apart. Stimulation of cellular immunity was confirmed for some candidates in plaque reduction neutralization tests.

3 April 2023
Verified
Other
Open access
BKBo Ram Kim
Bo Ram Kim
YJYoon A. Jeong
Yoon A. Jeong
MJMin Jee Jo
Min Jee Jo
SPSeong Hye Park
Seong Hye Park
YNYoo Jin Na
Yoo Jin Na
SOSang Cheul Oh
Sang Cheul Oh